UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 10-Q

(Mark One)

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
         SECURITIES EXCHANGE ACT OF 1934

         For the quarterly period ended    June 30, 2004
                                           -----------------

                                       OR

[  ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
         SECURITIES EXCHANGE ACT OF 1934

         For the transition period from                      to
                                            ----------------    ---------------


                         Commission file number 0-23367

                     BIRNER DENTAL MANAGEMENT SERVICES, INC.
-------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


                    COLORADO                                      84-1307044
-----------------------------------------------              -------------------
 (State or other jurisdiction of incorporation                  (IRS Employer
                or organization)                             Identification No.)


         3801 EAST FLORIDA AVENUE, SUITE 508
                  DENVER, COLORADO                           80210
------------------------------------------------------------------------
      (Address of principal executive offices)             (Zip Code)

                                 (303) 691-0680
-------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
-------------------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes      X     No
     --------      ---------

Indicate by check mark whether the Registrant is an accelerated filer
(as defined in Rule 12b-2 of the Exchange Act).
Yes             No     X
     ---------      -------

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

             Class                     Shares Outstanding as of August 12, 2004
-------------------------------        -----------------------------------------
Common Stock, without par value                        1,201,593


<PAGE>




            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
                               INDEX TO FORM 10-Q

PART I - FINANCIAL INFORMATION

<TABLE>
<CAPTION>
Item 1.   Financial Statements                                                                  Page
                                                                                                ----
<S>                                                                                               <C>
          Unaudited Condensed Consolidated Balance Sheets as of December 31, 2003
           and June 30, 2004                                                                      3

          Unaudited Condensed Consolidated Statements of Operations for the Quarters
           and Six Months Ended June 30, 2003 and 2004                                            4

          Unaudited Condensed Statement of Shareholders' Equity as of June 30, 2004               5

          Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months
           Ended June 30, 2003 and 2004                                                           6

          Unaudited Notes to Condensed Consolidated Financial Statements                          8

Item 2.   Management's Discussion and Analysis of Financial Condition
            And Results of Operations                                                            11

Item 3.   Quantitative and Qualitative Disclosures About Market Risk                             19

Item 4.   Controls and Procedures                                                                19

PART II - OTHER INFORMATION

Item 1.   Legal Proceedings                                                                      20

Item 4.   Submission of Matters to a Vote of Security Holders                                    20

Item 5.   Other Information                                                                      20

Item 6.    Subsequent Events                                                                     20

Item 7.   Exhibits and Reports on Form 8-K                                                       21

Signatures                                                                                       22
</TABLE>


                                       2
<PAGE>


                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                                    December 31,          June 30,
                                     ASSETS                                             2003                2004
                                                                                  -------------         -------------
                                                                                         **              (Unaudited)
<S>                                                                                 <C>                  <C>
CURRENT ASSETS:
    Cash and cash equivalents                                                       $ 1,110,786          $   916,005
    Accounts receivable, net of allowance for doubtful accounts
       of $215,838 and $230,495, respectively                                         2,673,041            2,897,163
    Deferred tax asset                                                                  121,475              121,475
    Prepaid expenses and other assets                                                   736,424              531,818
                                                                                    -----------          -----------
                Total current assets                                                  4,641,726            4,466,461

PROPERTY AND EQUIPMENT, net                                                           2,680,169            2,367,461

OTHER NONCURRENT ASSETS:
    Intangible assets, net                                                           14,732,349           14,352,190
    Deferred charges and other assets                                                   155,461              157,358
                                                                                    -----------          -----------
                Total assets                                                        $22,209,705          $21,343,470
                                                                                    ===========          ===========

                       LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
    Accounts payable and accrued expenses                                           $ 3,990,467          $ 4,452,539
    Income taxes payable                                                                190,883              198,100
    Current maturities of long-term debt                                                351,847              364,302
                                                                                    -----------          -----------
             Total current liabilities                                                4,533,197            5,014,941

LONG-TERM LIABILITIES:
    Deferred tax liability, net                                                         349,801              349,801
    Long-term debt, net of current maturities                                         2,735,576            1,150,506
    Other long-term obligations                                                         179,884              176,636
                                                                                    -----------          -----------
                Total liabilities                                                     7,798,458           6,691,884


SHAREHOLDERS' EQUITY:
    Preferred Stock, no par value, 10,000,000 shares
       authorized; none outstanding                                                           -                    -
    Common Stock, no par value, 20,000,000 shares
       authorized; 1,203,511 and 1,196,593 shares issued and
       outstanding, respectively                                                     12,428,363           11,994,098
    Retained earnings                                                                 1,982,884            2,657,488
                                                                                    -----------          -----------
                Total shareholders' equity                                           14,411,247           14,651,586
                                                                                    -----------          -----------
                Total liabilities and shareholders' equity                          $22,209,705          $21,343,470
                                                                                    ===========          ===========
</TABLE>

**  Derived from the Company's audited consolidated balance sheet at
    December 31, 2003

              The accompanying notes are an integral part of these
                     condensed consolidated balance sheets.

                                       3
<PAGE>

            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                              Quarters Ended                  Six Months Ended
                                                                 June 30,                           June 30,
                                                       ---------------------------       -----------------------------
                                                           2003            2004             2003               2004
                                                       -----------     -----------       -----------       -----------
<S>                                                    <C>             <C>               <C>               <C>
NET REVENUE                                            $ 7,880,470     $ 8,085,785       $15,609,228       $16,178,144
DIRECT EXPENSES:
    Clinical salaries and benefits                       3,002,902       3,027,701         6,013,741         6,079,706
    Dental supplies                                        478,576         496,777           923,173           960,912
    Laboratory fees                                        669,624         640,350         1,269,126         1,270,546
    Occupancy    870,260                                   879,985       1,733,968         1,767,543
    Advertising and marketing                               95,719         190,816           193,658           337,766
    Depreciation and amortization                          565,459         458,127         1,147,486           930,471
    General and administrative                             777,848         869,436         1,529,088         1,692,570
                                                       -----------     -----------       -----------       -----------
                                                         6,460,388       6,563,192        12,810,240        13,039,514
                                                       -----------     -----------       -----------       -----------
    Contribution from dental offices                     1,420,082       1,522,593         2,798,988         3,138,630

CORPORATE EXPENSES:
       General and administrative                          811,860         743,867         1,611,698         1,561,956
       Depreciation and amortization                        74,767          54,325           154,749           110,922
                                                       -----------     -----------       -----------       -----------

    Operating income                                       533,455         724,401         1,032,541         1,465,752
    Interest expense, net                                   35,845          17,386            88,648            43,710

    Income before income taxes                             497,610         707,015           943,893         1,422,042
    Income tax expense                                     189,093         282,806           358,679           568,817


    Net income                                         $   308,517      $   424,209      $   585,214        $   853,225
                                                       ===========      ===========      ===========        ===========


Net income per share of Common Stock:

    Basic                                              $       .23      $       .36      $       .43        $       .72
                                                       ===========      ===========      ===========        ===========

    Diluted                                            $       .21      $       .33      $       .39        $       .66
                                                       ===========      ===========      ===========        ===========


Weighted average number of shares of Common Stock and dilutive securities:

    Basic                                                1,341,461       1,189,791         1,374,195         1,189,221
                                                         =========       =========         =========         =========

    Diluted                                              1,476,919       1,298,301         1,505,183         1,297,063
                                                         =========       =========         =========         =========
</TABLE>


              The accompanying notes are an integral part of these
                  condensed consolidated financial statements.

                                       4
<PAGE>

            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
                                   (UNAUDITED)




<TABLE>
<CAPTION>
                                                             Common Stock                                     Total
                                                      ---------------------------         Retained         Shareholders'
                                                       Shares           Amount            Earnings            Equity
                                                      ---------      ------------        ----------        -------------
<S>                                                   <C>            <C>                 <C>               <C>
BALANCES, December 31, 2003                           1,203,511      $ 12,428,363        $1,982,884        $ 14,411,247
   Common Stock options exercised                        34,582           111,165                 -             111,165
   Purchase and retirement of Common Stock              (41,500)         (545,430)                -            (545,430)
   Dividends declared on Common Stock                         -                 -          (178,621)           (178,621)
   Net income                                                 -                 -           853,225             853,225
                                                      ---------      ------------        ----------         -----------
BALANCES, June 30, 2004                               1,196,593      $ 11,994,098        $2,657,488         $14,651,586
                                                      =========      ============        ==========         ===========
</TABLE>























              The accompanying notes are an integral part of these
                  condensed consolidated financial statements.

                                       5
<PAGE>


                                                                     Page 1 of 2
            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                              Six Months Ended
                                                                                                   June 30,
                                                                                      --------------------------------
                                                                                           2003                2004
                                                                                      -------------         ----------
<S>                                                                                   <C>                   <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
    Net income                                                                        $    585,214          $  853,225
    Adjustments to reconcile net income to net
       cash provided by operating activities:
          Depreciation and amortization                                                  1,302,235           1,041,393
          Loss on disposition of property                                                    5,942                 194
          Provision for doubtful accounts                                                    2,646              14,657
          Amortization of debt issuance costs                                               17,573               1,703
    Changes in assets and liabilities, net of effects from acquisitions:

          Accounts receivable                                                             (132,565)           (238,779)
          Prepaid expenses and other assets                                                258,585             204,606
          Deferred charges and other assets                                                      -              (3,600)
          Accounts payable and accrued expenses                                            (66,312)            372,327
          Income taxes payable                                                             108,678               7,217
          Other long-term obligations                                                        4,679              (3,248)
                                                                                       -----------         ------------
              Net cash provided by operating activities                                  2,086,675           2,249,695


CASH FLOWS FROM INVESTING ACTIVITIES:
    Capital expenditures                                                                  (176,097)           (348,720)
                                                                                       ------------        ------------
                 Net cash used in investing activities                                    (176,097)           (348,720)


CASH FLOWS FROM FINANCING ACTIVITIES:
    Advances - line of credit                                                            4,625,000           8,450,000
    Repayments - line of credit                                                         (4,625,000)         (9,850,000)
    Repayment of bank term-loan                                                           (570,000)                  -
    Repayment of long-term debt                                                           (171,314)           (172,615)
    Payment of debt issuance and financing costs                                            (1,750)                  -
    Proceeds from exercise of Common Stock options                                         151,011             111,165
    Purchase and retirement of Common Stock                                             (1,485,882)           (545,430)
    Common Stock cash dividends                                                                  -             (88,876)
    Other                                                                                    9,660                   -
                                                                                       -----------         -----------
              Net cash used in financing activities                                     (2,068,275)         (2,095,756)

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                                      (157,697)           (194,781)
CASH AND CASH EQUIVALENTS, beginning of period                                           1,072,757           1,110,786
                                                                                       -----------         -----------

CASH AND CASH EQUIVALENTS, end of period                                               $   915,060         $   916,005
                                                                                       ===========         ===========
</TABLE>





              The accompanying notes are an integral part of these
                  condensed consolidated financial statements.

                                       6
<PAGE>
                                                                     Page 2 of 2

            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                              Six Months Ended
                                                                                                   June 30,
                                                                                      --------------------------------
                                                                                           2003                2004
                                                                                      -------------         ----------
<S>                                                                                   <C>                   <C>
SUPPLEMENTAL DISCLOSURE OF CASH
    FLOW INFORMATION:

       Cash paid during the period for interest                                      $     105,423         $      76,215
                                                                                     =============         =============

       Cash paid during the period for income taxes                                  $     250,000         $     561,600
                                                                                     =============         =============

       Dividends payable at period end                                               $           -         $      89,745
                                                                                     =============         =============
</TABLE>




















              The accompanying notes are an integral part of these
                  condensed consolidated financial statements.

                                       7
<PAGE>


            BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
                               SEPTEMBER 30, 2003

(1)    UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The financial statements included herein have been prepared by Birner Dental
Management Services, Inc. (the "Company") pursuant to the rules and regulations
of the Securities and Exchange Commission. Certain information and footnote
disclosures normally included in financial statements prepared in accordance
with accounting principles generally accepted in the United States have been
condensed or omitted pursuant to such rules and regulations, although the
Company believes that the disclosures included herein are adequate to make the
information presented not misleading. A description of the Company's accounting
policies and other financial information is included in the audited consolidated
financial statements as filed with the Securities and Exchange Commission in the
Company's Annual Report on Form 10-K for the year ended December 31, 2003.

In the opinion of management, the accompanying unaudited condensed consolidated
financial statements contain all adjustments necessary to present fairly the
financial position of the Company as of June 30, 2004 and the results of
operations and cash flows for the periods presented. All such adjustments are of
a normal recurring nature. The results of operations for the quarter and six
months ended June 30, 2004 are not necessarily indicative of the results that
may be achieved for a full fiscal year and cannot be used to indicate financial
performance for the entire year.

(2)    SIGNIFICANT ACCOUNTING POLICIES

       Stock Options

The Company accounts for stock options using the intrinsic value method wherein
compensation expense is recognized on stock options granted only for the excess
of the market price of our Common Stock over the option exercise price on the
date of grant. All options of the Company are granted at amounts equal to or
higher than the fair value of our Common Stock, so no compensation expense is
recorded.

Some companies also recognize compensation expense for the fair value of the
option right itself. The Company has elected not to adopt this accounting method
because it requires the use of subjective valuation models which the Company
believes are not representative of the real value of the option to either the
Company or the optionees. However, we are required to disclose the pro forma
effect of accounting for stock options using such a valuation for all options
granted. The fair value of the options was estimated at the date of grant using
a Black-Scholes option-pricing model with the following weighted average
assumptions:

<TABLE>
<CAPTION>
                                         Three Months Ended           Six Months Ended
                                              June 30,                    June 30,
                                         --------------------     ---------------------
                                          2003         2004         2003        2004
                                         ------     ---------     ---------  ----------
       <S>                                 <C>      <C>           <C>        <C>
       Risk-free interest rate               *          3.00%         2.39%      2.33%
       Expected dividend yield              0%          1.88%            0%      1.88%

       Expected lives                        *      3.4 years     3.4 years  3.4 years
       Expected volatility                 57%            45%           57%        37%
</TABLE>

* There were no options granted during the second quarter of 2003.

To estimate lives of options for this valuation, it was assumed options would be
exercised one year after becoming fully vested. All options are initially
assumed to vest. Cumulative compensation cost recognized in pro forma net income
or loss with respect to options that are forfeited prior to vesting is adjusted
as a reduction of pro forma compensation expense in the period of forfeiture.
Fair value computations are highly sensitive to the volatility factor assumed;
the greater the volatility, the higher the computed fair value of options
granted.

There were no options granted during the quarter ended June 30, 2003. The total
fair value of options and warrants granted was computed to be approximately
$10,000 for the three months ended June 30, 2004 and $469,000 and $24,000 for
the six months ended June 30, 2003 and 2004, respectively. These amounts are
amortized ratably over the vesting periods of the options or recognized at the
date of grant if no vesting period is required. Pro forma stock-based
compensation, net of the effect of forfeitures, was ($66,000) and $51,000 for
the quarters ended June 30, 2003 and 2004, respectively, and $377,000 and
$39,000 for the six months ended June 30, 2003 and 2004, respectively.

                                       8
<PAGE>

If the Company had accounted for its stock-based compensation plans in
accordance with Statement of Financial Accounting Standards ("SFAS") No. 123,
the Company's net income and net income per common share would have been
reported as follows:

<TABLE>
<CAPTION>
                                                                     Three Months Ended             Six Months Ended
                                                                          June 30,                      June 30,
                                                                  -----------------------       -------------------------
                                                                     2003          2004           2003            2004
                                                                  ---------     ---------       ---------       ---------
<S>                                                               <C>           <C>             <C>             <C>
Net income, as reported                                           $ 308,517     $ 424,209       $ 585,214       $ 853,225
Stock-based compensation included in net income                           -             -               -               -
Fair value of stock-based compensation, net of income taxes          40,619      ( 31,187)       (233,973)        (23,647)
                                                                  ---------     ---------       ---------       ---------
Pro forma net income                                              $ 349,136     $ 393,022       $ 351,241       $ 829,578
                                                                  =========     =========       =========       =========

Net income per share, basic:
      As reported                                                     $ .23         $ .36          $  .43           $ .72

    Stock-based compensation included in net income                       -             -               -               -
      Fair value of stock-based compensation, net of income taxes       .03          (.03)           (.17)           (.02)
                                                                      -----         -----          ------           -----
      Pro forma                                                       $ .26         $ .33          $  .26           $ .70
                                                                      =====         =====          ======           =====

Net income per share, diluted:
      As reported                                                     $ .21         $ .33          $  .39           $ .66

    Stock-based compensation included in net income                       -             -               -               -
      Fair value of stock-based compensation, net of income taxes       .03          (.03)           (.16)           (.02)
                                                                      -----         -----          ------           -----
      Pro forma                                                       $ .24         $ .30          $  .23           $ .64
                                                                      =====         =====          ======           =====
</TABLE>

Weighted  average  shares used to calculate  pro forma net income per share were
determined as described in Note 3, except in applying the treasury  stock method
to  outstanding  options,  net proceeds  assumed  received  upon  exercise  were
increased by the amount of  compensation  cost  attributable  to future  service
periods and not yet recognized as pro forma expense.

  (3)   EARNINGS PER SHARE

The Company calculates earnings per share in accordance with SFAS No. 128
"Earnings Per Share".

<TABLE>
<CAPTION>
                                                                      Quarters Ended June 30,
                                           -------------------------------------------------------------------------
                                                           2003                                    2004
                                           ---------------------------------       ---------------------------------
                                                                   Per Share                               Per Share
                                             Income       Shares     Amount          Income       Shares     Amount
                                           ---------    ---------- ---------       ----------    --------- ---------
<S>                                        <C>           <C>         <C>           <C>           <C>         <C>
Basic EPS:
   Net income available to
     shares of Common Stock                $ 308,157     1,341,461   $ .23         $  424,209    1,189,791   $ .36

   Effect of dilutive shares of
     Common Stock from stock
     options and warrants                          -       135,458    (.02)                 -      108,510    (.03)

Diluted EPS:
                                           ---------    ----------   -----        -----------    ---------   -----
   Net income available to
      shares of Common Stock               $ 308,157     1,476,919   $ .21         $  424,209    1,298,301   $ .33
                                           =========     =========   =====         ==========    =========   =====
</TABLE>


The difference in weighted average shares outstanding between basic earnings per
share and diluted earnings per share for the quarters ended June 30, 2003 and
2004 relates to the effect of 135,458 and 108,510, respectively, of dilutive
shares of Common Stock from stock options and warrants which are included in
total shares for the diluted calculation.



                                       9
<PAGE>

<TABLE>
<CAPTION>
                                                                      Quarters Ended June 30,
                                           -------------------------------------------------------------------------
                                                           2003                                    2004
                                           ---------------------------------       ---------------------------------
                                                                   Per Share                               Per Share
                                             Income       Shares     Amount          Income       Shares     Amount
                                           ---------    ---------- ---------       ----------    --------- ---------
<S>                                        <C>           <C>         <C>           <C>           <C>         <C>
Basic EPS:
   Net income available to
     shares of Common Stock                $ 585,214     1,374,195   $ .43         $  853,225    1,189,221   $ .72

   Effect of dilutive shares of
     Common Stock from stock
     options and warrants                          -       130,988    (.04)                 -      107,842    (.06)
                                           ---------     ---------  ------         ----------    ---------   -----
Diluted EPS:
   Net income available to
      shares of Common Stock               $ 585,214     1,505,183  $  .39         $  853,225    1,297,063   $ .66
                                           =========     =========  ======         ==========    =========   =====
</TABLE>


The difference in weighted average shares outstanding between basic earnings per
share and diluted earnings per share for the six months ended June 30, 2003 and
2004 relates to the effect of 130,988 and 107,842, respectively, of dilutive
shares of Common Stock from stock options and warrants which are included in
total shares for the diluted calculation.

(4) LINE OF CREDIT

On May 6, 2004 the Company amended its Credit Facility. The amended Credit
Facility allows the Company to borrow, on a revolving basis, an aggregate
principal amount not to exceed $4.0 million at either, or a combination of, the
Lender's Base Rate or at LIBOR plus a LIBOR Rate Margin, at the Company's
option. The Lender's Base Rate computes interest at the higher of the Lender's
"prime rate" or the Federal Funds Rate plus one-half percent (0.5%). The LIBOR
option computes interest at the LIBOR rate as of the date such LIBOR Rate loan
was made plus a LIBOR Rate margin of 1.75%. A commitment fee of 0.25% on the
average daily unused amount of the Revolving Loan commitment during the
preceding quarter will also be assessed. The Company may prepay any Base Rate
Loan at any time and any LIBOR Rate Loan upon not less than three business days
prior written notice given to the Lender, but the Company will be responsible
for any loss or cost incurred by the Lender in liquidating or employing deposits
required to fund or maintain the LIBOR rate Loan. The amended Credit Facility
expires on May 31, 2006. At June 30, 2004, the Company had $600,000 outstanding
and $3.4 million available for borrowing under the Revolving Loan. This
consisted of $300,000 outstanding under the Base Rate option and $300,000
outstanding under the LIBOR Rate option. The Credit Facility requires the
Company to maintain certain financial ratios on an ongoing basis. At June 30,
2004, the Company was in full compliance with all of its covenants under this
agreement.

(5)    CAPITAL COMMITMENTS

The Company has budgeted capital commitments for the next 12 months of
approximately $1.1 million. These include the development of three de novo
offices, two in the Phoenix, Arizona market and one in the Denver, Colorado
market. The total cost of opening these de novo offices is estimated to be
approximately $775,000. In addition, the Company is planning a major remodeling
of four of its existing offices, three of which are in the Denver, Colorado
market and one in the Colorado Springs, Colorado market. The estimated costs of
these remodels is approximately $280,000.


                                       10
<PAGE>



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

Forward-Looking Statements

The statements contained in this report that are not historical in nature are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. All statements, other than statements of
historical facts, included in this report that address activities, events or
developments that we expect, believe, intend or anticipate will or may occur in
the future, are forward-looking statements. When used in this document, the
words "estimate," "believe," anticipate," "project" and similar expressions are
intended to identify forward-looking statements. Forward-looking statements are
inherently subject to risks and uncertainties, many of which cannot be predicted
with accuracy and some of which might not even be anticipated. These
forward-looking statements include statements in this Item 2., "Management's
Discussion and Analysis of Financial Condition and Results of Operations,"
regarding intent, belief or current expectations of the Company or its officers
with respect to the development or acquisition of additional dental practices
("Offices") and the successful integration of such Offices into the Company's
network, recruitment of additional dentists, funding of the Company's expansion,
capital expenditures, payment or nonpayment of dividends and cash outlays for
income taxes.

Such forward-looking statements involve certain risks and uncertainties that
could cause actual results to differ materially from anticipated results. These
risks and uncertainties include regulatory constraints, changes in laws or
regulations concerning the practice of dentistry or dental practice management
companies, the availability of suitable new markets and suitable locations
within such markets, changes in the Company's operating or expansion strategy,
the general economy of the United States and the specific markets in which the
Company's Offices are located or are proposed to be located, trends in the
health care, dental care and managed care industries, as well as the risk
factors set forth in the "Management's Discussion and Analysis of Financial
Condition and Results of Operations - Risk Factors" section of the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2003, this
report, and other factors as may be identified from time to time in the
Company's filings with the Securities and Exchange Commission or in the
Company's press releases.

General

The following discussion relates to factors that have affected the results of
operations and financial condition of the Company for the quarters and six
months ended June 30, 2003 and 2004. This information should be read in
conjunction with the Company's Condensed Consolidated Financial Statements and
related Notes thereto included elsewhere in this report.

Overview

The Company was formed in May 1995, and current1y manages 54 Offices in
Colorado, New Mexico and Arizona staffed by 77 general dentists and 18
specialists. The Company derives all of its Revenue (as defined below) from its
Management Agreements with professional corporations ("P.C.s") which conduct the
practice at each Office. In addition, the Company assumes a number of
responsibilities when it acquires a new practice or develops a de novo Office,
which are set forth in a Management Agreement, as described below.

The Company was formed with the intention of becoming the leading provider of
business services to dental practices in Colorado. The Company's growth and
success in the Colorado market led to its expansion into the New Mexico and
Arizona markets. The Company's growth strategy is to focus on greater
utilization of existing physical capacity through recruiting more dentists and
support staff and through selective acquisitions and development of de novo
Offices.

Critical Accounting Policies

The Company's critical accounting policies are set forth in its Form 10-K for
the year ended December 31, 2003. There have been no changes to these policies
since the filing of that report.


                                       11
<PAGE>


Components of Revenue and Expenses

Total dental group practice revenue ("Revenue") represents the revenue of the
Offices reported at estimated realizable amounts, received from dental plans,
other third-party payors and patients for dental services rendered at the
Offices. The Company's Revenue is derived principally from fee-for-service
revenue and managed dental care revenue. Fee-for-service revenue consists of
P.C. revenue received from indemnity dental plans, preferred provider plans and
direct payments by patients not covered by any third-party payment arrangement.
Managed dental care revenue consists of P.C. revenue received from capitated
managed dental care plans, including capitation payments and patient
co-payments. Capitated managed dental care contracts are between dental benefits
organizations and the P.C.s.

Net revenue represents Revenue less amounts retained by the Offices. The amounts
retained by the Offices represent amounts paid as salary to employed dentists
and hygienists. The Company's net revenue is dependent on the Revenue of the
Offices. Management service fee revenue represents the net revenue earned by the
Company for the Offices for which the Company has Management Agreements, but
does not have control. Direct expenses consist of the expenses incurred by the
Company in connection with managing the Offices, including salaries and benefits
for personnel other than dentists and hygienists, dental supplies, dental
laboratory fees, occupancy costs, advertising and marketing, depreciation and
amortization and general and administrative (including office supplies,
equipment leases, management information systems and other expenses related to
dental practice operations). The Company also incurs personnel and
administrative expenses in connection with maintaining a corporate function that
provides management, administrative, marketing, development and professional
services to the Offices.

Under each of the Management Agreements, the Company manages the business and
marketing aspects of the Offices, including (i) providing capital, (ii)
designing and implementing marketing programs, (iii) negotiating for the
purchase of supplies, (iv) staffing, (v) recruiting, (vi) training of non-dental
personnel, (vii) billing and collecting certain fees for dental services
provided by the Offices, (viii) arranging for certain legal and accounting
services, and (ix) negotiating with managed care organizations. Under the
Management Agreements, the P.C. is responsible for, among other things (i)
supervision of all dentists and dental hygienists, (ii) complying with all laws,
rules and regulations relating to dentists and dental hygienists, and (iii)
maintaining proper patient records. The Company has made, and intends to make in
the future, loans to P.C.s in Colorado, New Mexico and Arizona to fund their
acquisition of dental assets from third parties in order to comply with the laws
of such states.

Under the typical Management Agreement used by the Company, the P.C. pays the
Company a management fee equal to the Adjusted Gross Center Revenue of the P.C.
less compensation paid to the dentists and dental hygienists employed at the
Office of the P.C. Adjusted Gross Center Revenue is comprised of all fees and
charges booked each month by or on behalf of the P.C. as a result of dental
services provided to patients at the Office, less any adjustments for
uncollectible accounts, professional courtesies and other activities that do not
generate a collectible fee. The Company's costs include all direct and indirect
costs, overhead and expenses relating to the Company's provision of management
services at each Office under the Management Agreement, including (i) salaries,
benefits and other direct costs of employees who work at the Office (other than
dentist and hygienist salaries), (ii) direct costs of all Company employees or
consultants who provide services to or in connection with the Office, (iii)
utilities, janitorial, laboratory, supplies, advertising and other expenses
incurred by the Company in carrying out its obligations under the Management
Agreement, (iv) depreciation expense associated with the P.C.'s assets and the
assets of the Company used at the Office, and the amortization of intangible
asset value relating to the Office, (v) interest expense on indebtedness
incurred by the Company to finance any of its obligations under the Management
Agreement, (vi) general and malpractice insurance expenses, lease expenses and
dentist recruitment expenses, (vii) personal property and other taxes assessed
against the Company's or the P.C.'s assets used in connection with the operation
of the Office, (viii) out-of-pocket expenses of the Company's personnel related
to mergers or acquisitions involving the P.C., (ix) corporate overhead charges
or any other expenses of the Company, including the P.C.'s pro rata share of the
expenses of the accounting and computer services provided by the Company, and
(x) a collection reserve in the amount of 5.0% of Adjusted Gross Center Revenue.
As a result, substantially all costs associated with the provision of dental
services at the Offices are borne by the Company, other than the compensation of
the dentists and hygienists who work at the Offices of the P.C.'s. This enables
the Company to manage the profitability of the Offices. Each Management
Agreement is for a term of 40 years. Further, each Management Agreement
generally may be terminated by the P.C. only for cause, which includes a
material default by or bankruptcy of the Company. Upon expiration or termination
of a Management Agreement by either party, the P.C. must satisfy all obligations
it has to the Company.


                                       12
<PAGE>


The Company's Revenue is derived principally from fee-for-service revenue and
managed dental care revenue. Fee-for-service revenue consists of P.C. revenue
received from indemnity dental plans, preferred provider plans and direct
payments by patients not covered by any third-party payment arrangement. Managed
dental care revenue consists of P.C. revenue received from capitated managed
dental care plans, including capitation payments and patient co-payments.
Capitated managed dental care contracts are between dental benefits
organizations and the P.C.s. Under the Management Agreements, the Company
negotiates and administers these contracts on behalf of the P.C.s. Under a
capitated managed dental care contract, the dental group practice provides
dental services to the members of the dental benefits organization and receives
a fixed monthly capitation payment for each plan member covered for a specific
schedule of services regardless of the quantity or cost of services to the
participating dental group practice obligated to provide them. This arrangement
shifts the risk of utilization of these services to the dental group practice
providing the dental services. Because the Company assumes responsibility under
the Management Agreements for all aspects of the operation of the dental
practices (other than the practice of dentistry) and thus bears all costs of the
P.C.s associated with the provision of dental services at the Offices (other
than compensation and benefits of dentists and hygienists), the risk of
over-utilization of dental services at the Offices under capitated managed
dental care plans is effectively shifted to the Company. In addition, dental
group practices participating in a capitated managed dental care plan often
receive supplemental payments for more complicated or elective procedures. In
contrast, under traditional indemnity insurance arrangements, the insurance
company pays whatever reasonable charges are billed by the dental group practice
for the dental services provided.

The Company seeks to increase its fee-for-service business by increasing the
patient volume at existing Offices through effective marketing and advertising
programs and by opening new Offices. The Company seeks to supplement this
fee-for-service business with revenue from contracts with capitated managed
dental care plans. Although the Company's fee-for-service business generally is
more profitable than its capitated managed dental care business, capitated
managed dental care business serves to increase facility utilization and dentist
productivity. The relative percentage of the Company's Revenue derived from
fee-for-service business and capitated managed dental care contracts varies from
market to market depending on the availability of capitated managed dental care
contracts in any particular market and the Company's ability to negotiate
favorable contract terms. In addition, the profitability of managed dental care
Revenue varies from market to market depending on the level of capitation
payments and co-payments in proportion to the level of benefits required to be
provided. Historically, the Company has experienced a decrease in capitation
premiums received from insurance companies' managed care plans for which the
Company's affiliated Offices are providers. The Company believes this decrease
in capitation premiums has been caused by insurance companies decreasing the
scope of or in some cases, discontinuing altogether, their managed care
products, a trend the Company believes will continue. The Company has
experienced and expects to continue to experience an increase in patient visits
with Preferred Provider Organization ("PPO") insurance and believes a
significant portion of this increase has been the result of patients moving from
insurance companies' managed care products to their PPO products.


                                       13
<PAGE>

Results of Operations

For the three months ended June 30, 2004, Revenue increased $542,000, or 4.9%,
to $11.7 million compared to $11.1 million for the three months ended June 30,
2003. For the three months ended June 30, 2004, net revenue increased $205,000,
or 2.6%, to $8.1 million compared to $7.9 million for the three months ended
June 30, 2003.

For the six months ended June 30, 2004, Revenue increased $1.3 million, or 6.1%,
to $23.4 million compared to $22.0 million for the six months ended June 30,
2003. For the six months ended June 30, 2004, net revenue increased to $16.2
million compared to $15.6 million for the six months ended June 30, 2003, an
increase of $569,000 or 3.6%.

Revenue is total dental group practice revenue generated at the Company's
offices from professional services provided to its patients. Amounts retained by
group practices represents compensation expense to the dentists and hygienists
and is subtracted from total dental group practice revenue to arrive at net
revenue. The Company reports net revenue in its financial statements to comply
with Emerging Issues Task Force Issue No. 97-2, Application of SFAS No. 94
(Consolidation of All Majority Owned Subsidiaries) and APB Opinion No. 16
(Business Combinations) to Physician Practice Management Entities and Certain
Other Entities With Contractual Management Arrangements. Revenue is not a
generally accepted accounting principles measure. The company discloses Revenue
because it is a critical component for management's evaluation of Office
performance. However, investors should not consider this measure in isolation or
as a substitute for net revenue, operating income, cash flows from operating
activities or any other measure for determining the Company's operating
performance or liquidity that is calculated in accordance with generally
accepted accounting principles. The following table reconciles Revenue to net
revenue.

<TABLE>
<CAPTION>
                                                Quarters Ended June 30,                 Six Months Ended June 30,
                                             -----------------------------         -------------------------------
                                                2003               2004                 2003               2004
                                             -----------      ------------         ------------       ------------
<S>                                          <C>              <C>                  <C>                <C>
Total dental group practice revenue          $11,121,493      $ 11,663,435         $ 22,034,074       $ 23,379,072
Amounts retained by group practices           (3,241,023)       (3,577,650)          (6,424,846)        (7,200,928)
                                             -----------      ------------         ------------       ------------
Net revenue                                  $ 7,880,470      $  8,085,785         $ 15,609,228       $ 16,178,144
                                             ===========      ============         ============       ============
</TABLE>


The following table sets forth the percentages of net revenue represented by
certain items reflected in the Company's Condensed Consolidated Statements of
Operations. The information contained in the table represents the historical
results of the Company. The information that follows should be read in
conjunction with the Company's Condensed Consolidated Financial Statements and
related Notes thereto contained elsewhere in this report.

<TABLE>
<CAPTION>
                                                  Quarters Ended June 30,         Six Months Ended June 30,
                                                  ------------------------        -------------------------
                                                    2003            2004            2003              2004
                                                    ----            ----            ----              ----
<S>                                                 <C>            <C>             <C>                <C>
Net revenue                                         100.0 %        100.0 %         100.0 %            100.0 %
Direct expenses:
   Clinical salaries and benefits                    38.1 %         37.4 %          38.5 %             37.6 %
   Dental supplies                                    6.1 %          6.1 %           5.9 %              5.9 %
   Laboratory fees                                    8.5 %          7.9 %           8.1 %              7.9 %
   Occupancy                                         11.0 %         10.9 %          11.1 %             10.9 %
   Advertising and marketing                          1.2 %          2.4 %           1.3 %              2.1 %
   Depreciation and amortization                      7.2 %          5.7 %           7.4 %              5.7 %
   General and administrative                         9.9 %         10.8 %           9.8 %             10.5 %
                                                    -------      ---------         -------          ---------
                                                     82.0 %         81.2 %          82.1 %             80.6 %
                                                    -------       --------        --------           --------
Contribution from dental offices                     18.0 %         18.8 %          17.9 %.            19.4 %

Corporate expenses:
   General and administrative                        10.3 %          9.2 %          10.3 %              9.6 %
   Depreciation and amortization                      0.9 %          0.7 %           1.0 %              0.7 %
                                                    -------       --------        --------           --------
Operating income                                      6.8 %          8.9 %           6.6 %              9.1 %
Interest expense, net                                 0.5 %          0.2 %           0.6 %              0.3 %
                                                    -------        -------         -------           --------
Income before income taxes                            6.3 %          8.7 %           6.0 %              8.8 %
Income tax expense                                    2.4 %          3.5 %           2.3 %              3.5 %
                                                    -------        -------         -------           --------
Net income                                            3.9 %          5.2 %           3.7 %              5.3 %
                                                    ========       =======         =======           ========
</TABLE>






                                       14
<PAGE>


Three Months Ended June 30, 2004 Compared to Three Months Ended June 30, 2003:

Net revenue. For the three months ended June 30, 2004, net revenue increased
$205,000, or 2.6%, to $8.1 million compared to $7.9 million for the three months
ended June 30, 2003. This is the result of more patients being seen because of
having 95 dentists on staff as of June 30, 2004 compared to 90 dentists as of
June 30, 2003 as well as the increase of advertising in the Denver and Colorado
Springs, Colorado markets.

Clinical salaries and benefits. For the three months ended June 30, 2004,
clinical salaries and benefits remained constant at $3.0 million as compared to
the three months ended June 30, 2003. As a percentage of net revenue, clinical
salaries and benefits decreased to 37.4% for the three months ended June 30,
2004 compared to 38.1% for the three months ended June 30, 2003.

Dental supplies. For the three months ended June 30, 2004, dental supplies
increased to $497,000 compared to $479,000 for the three months ended June 30,
2003, an increase of $18,000 or 3.8%. This increase is attributable to the
higher number of dentists working. As a percentage of net revenue, dental
supplies remained constant at 6.1% for the three months ended June 30, 2004
compared to the three months ended June 30, 2003.

Laboratory fees. For the three months ended June 30, 2004, laboratory fees
decreased to $640,000 compared to $670,000 for the three months ended June 30,
2003, a decrease of $29,000 or 4.4%. This decrease was due to the mix of
business during the quarter whereby there were fewer dental procedures performed
that required lab work compared to the corresponding period in 2003. As a
percentage of net revenue, laboratory fees decreased to 7.9% for the three
months ended June 30, 2004 compared to 8.5% for the three months June 30, 2003.

Occupancy. For the three months ended June 30, 2004, occupancy expense increased
to $880,000 compared to $870,000 for the three months ended June 30, 2003, an
increase of $10,000 or 1.1%. As a percentage of net revenue, occupancy expense
decreased to 10.9% for the three months ended June 30, 2004 compared to 11.0%
for the three months ended June 30, 2003.

Advertising and marketing. For the three months ended June 30, 2004, advertising
and marketing increased to $191,000 compared to $96,000 for the three months
ended June 30, 2003, an increase of $95,000 or 99.4%. This increase is primarily
due to the initiation of television advertising in the Colorado Springs,
Colorado market beginning in January 2004 and in the Denver, Colorado market
beginning in June 2004. As a percentage of net revenue, advertising and
marketing increased to 2.4% for the three months ended June 30, 2004 compared to
1.2% for the three months ended June 30, 2003.

Depreciation and amortization. For the three months ended June 30, 2004,
depreciation and amortization expenses attributable to the Offices decreased to
$458,000 compared to $565,000 for the three months ended June 30, 2003, a
decrease of $107,000 or 19.0%. The decrease in the Company's depreciable asset
base is a result of existing assets becoming fully depreciated. As a percentage
of net revenue, depreciation and amortization decreased to 5.7% for the three
months ended June 30, 2004 compared to 7.2% for the three months ended June 30,
2003.

General and administrative. For the three months ended June 30, 2004, general
and administrative expenses attributable to the Offices increased to $869,000
compared to $778,000 for the three months ended June 30, 2003, an increase of
$92,000 or 11.8%. The increase is primarily due to higher professional liability
insurance costs due to more general and specialty dentists working as well as
higher office supply costs and higher dentist recruiting costs. As a percentage
of net revenue, general and administrative expenses increased to 10.8% for the
three months ended June 30, 2004 compared to 9.9% during the three months ended
June 30, 2003.

Contribution from dental offices. As a result of the above, contribution from
dental offices increased $103,000, or 7.2%, to $1.5 million for the three months
ended June 30, 2004 compared to $1.4 million for the three months ended June 30,
2003. As a percentage of net revenue, contribution from dental offices increased
to 18.8% for the three months ended June 30, 2004 compared to 18.0% for the
three months ended June 30, 2003.

Corporate expenses - general and administrative. For the three months ended June
30, 2004, corporate expenses - general and administrative decreased to $744,000
compared to $812,000 for the three months ended June 30, 2003, a decrease of
$68,000 or 8.4%. This decrease is related primarily to outside professional
investment advisory fees incurred in the second quarter of 2003 that did not
recur during 2004. As a percentage of net revenue, corporate expense - general
and administrative decreased to 9.2% for the three months ended June 30, 2004
compared to 10.3% during the three months ended June 30, 2003.


                                       15
<PAGE>


Corporate expenses - depreciation and amortization. For the three months ended
June 30, 2004, corporate expenses - depreciation and amortization decreased to
$54,000 compared to $75,000 for the three months ended June 30, 2003, a decrease
of $20,000 or 27.3%. The decrease is related to the decrease in the Company's
depreciable asset base. As a percentage of net revenue, corporate expenses -
depreciation and amortization decreased to 0.7% for the three months ended June
30, 2004 compared to 0.9% for the three months ended June 30, 2003.

Operating income. As a result of the matters discussed above, the Company
generated operating income of $724,000 for the three months ended June 30, 2004
compared to operating income of $533,000 for the three months ended June 30,
2003, an increase of $191,000 or 35.8%. As a percentage of net revenue,
operating income increased to 8.9% for the three months ended June 30, 2004
compared to 6.8% for the three months ended June 30, 2003.

Interest expense, net. For the three months ended June 30, 2004, interest
expense, net decreased to $17,000 compared to $36,000 for the three months ended
June 30, 2003, a decrease of $18,000 or 51.5%. This decrease in interest expense
is attributable to lower average outstanding debt balances and lower
amortization of debt acquisition costs. As a percentage of net revenue, interest
expense decreased to 0.2% for the three months ended June 30, 2004 compared to
0.5% for the three months ended June 30, 2003.

Net income. As a result of the above, the Company reported net income of
$424,000 for the three months ended June 30, 2004 compared to net income of
$309,000 for the three months ended June 30, 2003, an increase of $116,000 or
37.5%. Net income for the quarter ended June 30, 2004 was net of income tax
expense of $283,000 while net income for the quarter ended June 30, 2003 was net
of income tax expense of $189,000. As a percentage of net revenue, net income
increased to 5.2% for the three months ended June 30, 2004 compared to 3.9% for
the three months ended June 30, 2003.

Six Months Ended June 30, 2004 Compared to Six Months Ended June 30, 2003:

Net revenue. For the six months ended June 30, 2004, net revenue increased to
$16.2 million compared to $15.6 million for the six months ended June 30, 2003,
an increase of $569,000 or 3.6%. This is the result of more patients being seen
because of having 95 dentists on staff as of June 30, 2004 compared to 90
dentists as of June 30, 2003 as well as the increase of advertising in the
Denver and Colorado Springs, Colorado markets.

Clinical salaries and benefits. For the six months ended June 30, 2004, clinical
salaries and benefits increased to $6.1 million compared to $6.0 million for the
six months ended June 30, 2003, an increase of $66,000 or 1.1%. This increase
was primarily due to wage increases granted during the first quarter of 2004. As
a percentage of net revenue, clinical salaries and benefits decreased to 37.6%
for the six months ended June 30, 2004 compared to 38.5% for the six months
ended June 30, 2003.

Dental supplies. For the six months ended June 30, 2004, dental supplies
increased to $961,000 compared to $923,000 for the six months ended June 30,
2003, an increase of $38,000 or 4.1%. This increase is attributable to the
higher number of dentists working. As a percentage of net revenue, dental
supplies remained constant at 5.9% for the six months ended June 30, 2004
compared to the six months ended June 30, 2003.

Laboratory fees. For the six months ended June 30, 2004, laboratory fees
remained constant at $1.3 million compared to the six months ended June 30,
2003. As a percentage of net revenue, laboratory fees decreased to 7.9% for the
six months ended June 30, 2004 compared to 8.1% for the six months June 30,
2003.

Occupancy. For the six months ended June 30, 2004, occupancy expense increased
$34,000, or 1.9%, to $1.8 million compared to $1.7 million for the six months
ended June 30, 2003. This increase was primarily due to increased rental
payments resulting from the renewal of Office leases at current market rates for
Offices whose leases expired subsequent to the 2003 period. As a percentage of
net revenue, occupancy expense decreased to 10.9% for the six months ended June
30, 2004 compared to 11.1% for the six months ended June 30, 2003.

Advertising and marketing. For the six months ended June 30, 2004, advertising
and marketing increased to $338,000 compared to $194,000 for the six months
ended June 30, 2003, an increase of $144,000 or 74.4%. This increase is
primarily due to the initiation of television advertising in the Colorado
Springs, Colorado market beginning in January 2004 and in the Denver, Colorado
market beginning in June 2004. As a percentage of net revenue, advertising and
marketing increased to 2.1% for the six months ended June 30, 2004 compared to
1.3% for the six months ended June 30, 2003.


                                       16
<PAGE>

Depreciation and amortization. For the six months ended June 30, 2004,
depreciation and amortization expenses attributable to the Offices decreased to
$930,000 compared to $1.1 million for six months ended June 30, 2003, a decrease
of $217,000 or 18.9%. The decrease in the Company's depreciable asset base is a
result of existing assets becoming fully depreciated. As a percentage of net
revenue, depreciation and amortization decreased to 5.7% for the six months
ended June 30, 2004 compared to 7.4% for the six months ended June 30, 2003.

General and administrative. For the six months ended June 30, 2004, general and
administrative expenses attributable to the Offices increased to $1.7 million
compared to $1.5 million for the six months ended June 30, 2003, an increase of
$163,000 or 10.7%. The increase is primarily due to higher professional
liability insurance costs due to more general and specialty dentists working as
well as higher office supply costs and higher dentist recruiting costs. As a
percentage of net revenue, general and administrative expenses increased to
10.5% for the six months ended June 30, 2004 compared to 9.8% during the six
months ended June 30, 2003.

Contribution from dental offices. As a result of the above, contribution from
dental offices increased to $3.1 million for the six months ended June 30, 2004
compared to $2.8 million for the six months ended June 30, 2003, an increase of
$340,000 or 12.1%. As a percentage of net revenue, contribution from dental
offices increased to 19.4% for the six months ended June 30, 2004 compared to
17.9% for the six months ended June 30, 2003.

Corporate expenses - general and administrative. For the six months ended June
30, 2004, corporate expenses - general and administrative remained constant at
$1.6 million compared to the six months ended June 30, 2003. As a percentage of
net revenue, corporate expense - general and administrative decreased to 9.6%
for the six months ended June 30, 2004 compared to 10.3% for the six months
ended June 30, 2003.

Corporate expenses - depreciation and amortization. For the six months ended
June 30, 2004, corporate expenses - depreciation and amortization decreased to
$111,000 compared to $155,000 for the six months ended June 30, 2003, a decrease
of $44,000 or 28.3%. This decrease is related to the decrease in the Company's
depreciable asset base. As a percentage of net revenue, corporate expenses -
depreciation and amortization decreased to 0.7% for the six months ended June
30, 2004 compared to 1.0% for the six months ended June 30, 2003.

Operating income. As a result of the above, the Company generated operating
income of $1.5 million for the six months ended June 30, 2004 compared to
operating income of $1.0 million for the six months ended June 30, 2003, an
increase of $433,000 or 42.0%. As a percentage of net revenue, operating income
increased to 9.1% for the six months ended June 30, 2004 compared to 6.6% for
the six months ended June 30, 2003.

Interest expense, net. For the six months ended June 30, 2004 interest expense,
net decreased to $44,000 compared to $89,000 for the six months ended June 30,
2003, a decrease of $45,000 or 50.7%. This decrease in interest expense is
attributable to lower average outstanding debt balances and lower amortization
of debt acquisition costs. As a percentage of net revenue, interest expense
decreased to 0.3% for the six months ended June 30, 2004 compared to 0.6% for
the six months ended June 30, 2003.

Net income. As a result of the above, the Company reported net income of
$853,000 for the six months ended June 30, 2004 compared to net income of
$585,000 for the six months ended June 30, 2003, an increase of $268,000 or
45.8%. Net income for the six months ended June 30, 2004 was net of income tax
expense of $569,000 while the net income for the six months ended June 30, 2003
was net of income tax expense of $359,000. As a percentage of net revenue, net
income increased to 5.3% for the six months ended June 30, 2004 compared to 3.7%
for the six months ended June 30, 2003.

Liquidity and Capital Resources

The Company finances its operations and growth through a combination of cash
provided by operating activities, a bank line of credit (the "Credit Facility")
and, from time to time, seller notes.

Net cash provided by operating activities was approximately $2.2 million and
$2.1 million for the six months ended June 30, 2004 and 2003, respectively.
During 2004, excluding net income and after adding back non-cash items, the
Company's cash provided by operating activities consisted primarily of an
increase in accounts payable and accrued expenses of approximately $372,000 and
a decrease in prepaid expenses and other assets of approximately $205,000,
partially offset by an increase in accounts receivable of approximately
$239,000. During 2003, excluding net income and after adding back non-cash
items, the Company's cash provided by operating activities consisted primarily
of a decrease in prepaid expenses and other assets of approximately $259,000 and
an increase in income taxes payable of approximately $109,000, partially offset
by an increase in accounts receivable of approximately $133,000 and a decrease
in accounts payable of approximately $66,000.


                                       17
<PAGE>

Net cash used in investing activities was approximately $349,000 and $176,000
for the six months ended June 30, 2004 and 2003, respectively. These amounts
were used for the purchase of additional property and equipment in each period.

Net cash used in financing activities was approximately $2.1 million for both
the six months ended June 30, 2004 and 2003. During the six months ended June
30, 2004, net cash used in financing activities was comprised of approximately
$1.4 million paid down on the Company's Credit Facility, approximately $545,000
used in the purchase and retirement of Common Stock, approximately $173,000 for
the repayment of long-term debt and approximately $89,000 for the payment of
dividends, partially offset by $111,000 in proceeds from the exercise of Common
Stock options. During the six months ended June 30, 2003, net cash used in
financing activities was comprised of approximately $1.5 million used in the
purchase and retirement of Common Stock, approximately $570,000 used to reduce
the amount outstanding on the Company's Credit Facility and approximately
$171,000 for the repayment of long-term debt, partially offset by approximately
$151,000 in proceeds from the exercise of Common Stock options.

On May 6, 2004, the Company amended its Credit Facility Agreement. The amended
Credit Facility allows the Company to borrow, on a revolving basis, an aggregate
principal amount not to exceed $4.0 million at either, or a combination of, the
Lender's Base Rate or at LIBOR plus a LIBOR Rate Margin, at the Company's
option. The Lender's Base Rate computes interest at the higher of the Lender's
"prime rate" or the Federal Funds Rate plus one-half percent (0.5%). The LIBOR
option computes interest at the LIBOR rate as of the date such LIBOR Rate Loan
was made plus a LIBOR Rate Margin of 1.75%. A commitment fee of 0.25% on the
average daily unused amount of the Revolving Loan commitment during the
preceding quarter will also be assessed. The Company may prepay any Base Rate
Loan at any time and any LIBOR Rate Loan upon not less than three business days
prior written notice given to the Lender, but the Company will be responsible
for any loss or cost incurred by the Lender in liquidating or employing deposits
required to fund or maintain the LIBOR rate Loan. The amended Credit Facility
expires on May 31, 2006. At June 30, 2004, the Company had $600,000 outstanding
and $3.4 million available for borrowing under the Revolving Loan. This
consisted of $300,000 outstanding under the Base Rate Option and $300,000
outstanding under the LIBOR Rate option. The Credit Facility requires the
Company to maintain certain financial ratios on an ongoing basis. At June 30,
2004, the Company was in full compliance with all of its covenants under this
agreement.

At June 30, 2004, the Company had outstanding indebtedness of approximately
$915,000 represented by notes issued in connection with various dental practice
acquisitions, all of which bear interest at 8.0%. At June 30, 2004, the Company
had capital commitments of approximately $1.1 million related to the development
of three de novo offices and the remodeling of four existing offices. The
Company's retained earnings as of June 30, 2004 were approximately $2.7 million
and the Company had a working capital deficit on that date of approximately
$548,000.

The Company's earnings before interest, taxes, depreciation and amortization
("EBITDA") increased to $2.5 million for the six months ended June 30, 2004
compared to $2.3 million for the corresponding six-month period in 2003.
Although EBITDA is not a generally accepted accounting principles measure of
performance or liquidity, the Company believes that it may be useful to an
investor in evaluating its performance. However, investors should not consider
this measure in isolation or as a substitute for operating income, cash flows
from operating activities or any other measure for determining the Company's
operating performance or liquidity that is calculated in accordance with
generally accepted accounting principles. In addition, because EBITDA is not
calculated in accordance with generally accepted accounting principles, it may
not necessarily be comparable to similarly titled measures employed by other
companies. A reconciliation of EBITDA can be made by adding depreciation and
amortization expense - offices, depreciation and amortization expense -
corporate, interest expense, net and income tax expense to net income as in the
table below.

<TABLE>
<CAPTION>
                                                        Quarters Ended June 30,           Six Months Ended June 30,
                                                     -----------------------------      -----------------------------
                                                         2003             2004              2003             2004
                                                     -----------       -----------      -----------       -----------
<S>                                                  <C>               <C>             <C>                <C>
RECONCILIATION OF EBITDA:
    Net income                                       $   308,517       $   424,209     $    585,214       $   853,225
    Depreciation and amortization - Offices              565,459           458,127        1,147,486           930,471
    Depreciation and amortization - Corporate             74,767            54,325          154,749           110,922
    Interest expense, net                                 35,845            17,386           88,648            43,710
    Income tax expense                                   189,093           282,806          358,679           568,817
                                                     -----------       -----------      -----------       -----------

EBITDA                                               $ 1,173,681       $ 1,236,853      $ 2,334,776       $ 2,507,145
                                                     ===========       ===========      ===========       ===========
</TABLE>


The Company's contractual obligations have not materially changed from those
disclosed in the table included in the Company's filing on Form 10-K for the
year ended December 31, 2003.


                                       18
<PAGE>



The Company from time to time may purchase its Common Stock on the open market
for treasury stock. During 2002, the Company, in 93 separate transactions,
purchased 117,236 shares of its Common Stock for total consideration of
approximately $1.2 million at prices ranging from $7.35 to $11.25 per share, of
which approximately $60,000 was recorded as compensation expense in accordance
with Financial Accounting Standards Board Interpretation Number 44. During 2003,
the Company, in 84 separate transactions, purchased 296,195 shares of its Common
Stock for total consideration of approximately $3.9 million at prices ranging
from $9.54 to $14.20 per share. During the six month period ended June 30, 2004,
the Company, in four separate transactions, purchased 41,500 shares of its
Common Stock for total consideration of approximately $545,000 at prices ranging
from $12.65 to $13.30 per share. On August 10, 2004, the Board of Directors
authorized the Company to make up to an additional $500,000 in open-market
purchases of its Common Stock. Such purchases may be made from time to time as
the Company's management deems appropriate.

The Company believes that cash generated from operations and borrowings under
its Credit Facility will be sufficient to fund its anticipated working capital
and capital expenditure needs and dividend payments for at least the next 12
months. In the event the Company is not able to successfully negotiate a new
Credit Facility at the end of its term in May 2006, the Company's current
sources of liquidity may not be adequate. In addition, in order to meet its
long-term liquidity needs the Company may issue additional equity and debt
securities, subject to market and other conditions. There can be no assurance
that such additional financing will be available on terms acceptable to the
Company. The failure to raise the funds necessary to finance its future cash
requirements could adversely affect the Company's ability to pursue its strategy
and could negatively affect its operations in future periods.

 ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk represents the risk of loss that may impact the financial position,
results of operations or cash flows of the Company due to adverse changes in
financial and commodity market prices and rates. The Company is exposed to
market risk in the area of changes in interest rates. Historically and as of
June 30, 2004, the Company has not used derivative instruments or engaged in
hedging activities.

Interest Rate Risk. The interest payable on the Company's Credit Facility is
variable based upon the prime rate and the LIBOR rate and, therefore, is
affected by changes in market interest rates. At June 30, 2004, $300,000 was
outstanding with an interest rate of 4.25% (Prime) and $300,000 was outstanding
with an interest rate of 3.0025% (LIBOR 30 day rate plus 1.75%). The Company
does not believe that reasonably possible near-term changes in interest rates
will result in a material effect on future earnings, fair values or cash flows
of the Company. Based on calculations performed by the Company, a 1.0% increase
in the Company's interest rate would result in additional interest expense of
approximately $6,100 for the six months ended June 30, 2004.

ITEM 4.  CONTROLS AND PROCEDURES

The effectiveness of our or any system of disclosure controls and procedures is
subject to certain limitations, including the exercise of judgment in designing,
implementing and evaluating the controls and procedures, the assumptions used in
identifying the likelihood of future events, and the inability to eliminate
misconduct completely. As a result, there can be no assurance that our
disclosure controls and procedures will detect all errors or fraud. By their
nature, our or any system of disclosure controls and procedures can provide only
reasonable assurance regarding management's control objectives.

Under the supervision and with the participation of our management, including
our Chief Executive Officer and Chief Financial Officer, we evaluated the design
and operation of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, or the "Exchange
Act") as of June 30, 2004. On the basis of this review, our management,
including our Chief Executive Officer and Chief Financial Officer, concluded
that our disclosure controls and procedures are designed, and are effective, to
give reasonable assurance that the information required to be disclosed by us in
reports that we file under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the SEC
and to ensure that information required to be disclosed in the reports filed or
submitted under the Exchange Act is accumulated and communicated to our
management, including our Chief Executive Officer and Chief Financial Officer,
in a manner that allows timely decisions regarding required disclosure, There
were no changes in the Company's internal controls over financial reporting that
occurred in the second quarter of 2004 that materially affected, or were
reasonably likely to materially affect, its internal control over financial
reporting.


                                       19
<PAGE>



                           PART II. OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

From time to time the Company is subject to litigation incidental to its
business. The Company is not presently a party to any material litigation. Such
claims, if successful, could result in damage awards exceeding, perhaps
substantially, applicable insurance coverage.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

(a) The Company's Annual Meeting of Shareholders was held on June 8, 2004.

(b) The following directors were elected at the meeting to serve a three-year
term as Class I directors:

                                       For       Withheld Authority      Abstain
                                    ---------    ------------------      -------
     James M. Ciccarelli            1,082,906            187                0
     Paul E. Valuck, D.D.S.         1,082,888            205                0

Continuing Directors

After the meeting, the following directors continued to serve their three-year
terms as Class II directors, which terms will expire at the Company's annual
meeting in 2005:

     Dennis N. Genty
     Brooks G. O'Neil

After the meeting, the following directors continued to serve their three-year
terms as Class III directors, which terms will expire at the Company's annual
meeting in 2006:

     Frederic W.J. Birner
     Mark A. Birner, D.D.S.

(c) Other matters voted upon at the meeting and results of those votes are as
follows:

     Authorization to increase shares of the Company's Common Stock available
     under the 1995 employee stock option plan by 150,000 shares:

             For         Against         Abstain       Not Voted
             ---         -------         -------       ---------
           725,959        61,821               0         295,313


     The matters mentioned above are described in detail in the Company's
     definitive proxy statement dated May 7, 2004 for the Annual Meeting of
     Shareholders held on June 8, 2004.

ITEM 5.   OTHER INFORMATION

On June 8, 2004, Thomas D. Wolf was appointed a director of the Company. The
appointment enabled the Company to be in compliance with applicable Nasdaq rules
that require that a majority of the Company's directors must be independent
according to specified criteria.

ITEM 6.   SUBSEQUENT EVENTS

On August 10, 2004, the Board of Directors authorized the Company to make up to
an additional $500,000 in open-market purchases of its Common Stock. Such
purchases may be made from time to time as the Company's management deems
appropriate.


                                       20
<PAGE>


ITEM 7.   EXHIBITS AND REPORTS ON FORM 8-K

(a)          Exhibits

Exhibit
Number       Description of Document
--------     -----------------------
31.1         Rule 13a-14(a) Certification of the Chief Executive Officer.

31.2         Rule 13a-14(a) Certification of the Chief Financial Officer.

32.1         Section 1350 Certifications of the Chief Executive Officer and
             the Chief Financial Officer.


(b) Reports on Form 8-K

             On May 6, 2004, the Company furnished a report on Form 8-K related
             to reporting of financial results for the first quarter of 2004.

             On June 21, 2004, the Company filed a report on From 8-K announcing
             the declaration of a quarterly dividend.



                                       21
<PAGE>




                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                    BIRNER DENTAL MANAGEMENT SERVICES, INC.



Date: August 12, 2004    By:  /s/ Frederic W.J. Birner
                              -------------------------------------------------
                        Name: Frederic W.J. Birner
                       Title: Chairman of the Board and Chief Executive Officer
                              (Principal Executive Officer)

Date: August 12, 2004     By: /s/ Dennis N. Genty
                              ------------------------------------------------
                        Name: Dennis N. Genty
                       Title: Chief Financial Officer, Secretary, and Treasurer
                              (Principal Financial and Accounting Officer)


                                       22